Although one report indicated that protein expression of CDC25B in GBM tissue is not upregulated in cases with chemo- or ratio-resistance [171], these evidences suggest and an oncogenic rather than a tumor-suppressive role of CDC25B. This evidence concerns the gene CDC25B and glioblastoma.